$95 for Genentech = Too Low
The Financial Times today reported that Roche was preparing a $95 bid for Genentech (Ticker: DNA). Another low ball bid in my opinion! Genentech will not sell out for cheap. Roche has to go over $100 for me to even consider giving up my shares in Genentech. Roche likes to drag things out, but they will eventually come to their senses and pay up.
1 Comments:
So that's why DNA keeps going higher and higher!!!
Post a Comment
<< Home